Healthcare -
Biotechnology - NASDAQ - US
$ 2.237
1.68 %
$ 59.3 M
Market Cap
-2.09
P/E
GANX - LONG-TERM DEBT
Long-term Debt GANX - Gain Therapeutics, Inc.
679 K
LAST VALUE
-27.33%
2 YEAR CAGR
-10.88%
5 YEAR CAGR
0.00%
10 YEAR CAGR